Earnings Call Insights: Takeda Pharmaceutical Company Limited (NYSE ... to the lack of prior transcript data. However, ...

Net Income Growth 5Y: 28.35% Takeda Pharmaceutical Company Limited (NYSE:TAK) is a leading global biopharmaceutical company with a rich history dating back to 1781. It is the third-largest ...

Last year, Takeda firmly cemented its place in the emerging markets when it acquired Swiss pharma company, Nycomed, for US $13.7bn. According to a recent report, Russia’s pharmaceutical market ...